Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.

Abstract

BACKGROUND The extent to which individual statins vary in terms of clinical outcomes across all populations, in addition to secondary and primary prevention has not been studied extensively in meta-analyses. METHODS We systematically studied 199,721 participants in 92 placebo-controlled and active-comparator trials comparing atorvastatin, fluvastatin… (More)
DOI: 10.1177/2047487313480435

Topics

8 Figures and Tables

Cite this paper

@article{Naci2013ComparativeBO, title={Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.}, author={Huseyin Naci and Jasper Jan Brugts and Rachael Fleurence and Bernice Tsoi and Harleen Toor and Anthony E. Ades}, journal={European journal of preventive cardiology}, year={2013}, volume={20 4}, pages={641-57} }